UNITED STATES ACUTE CARE AT HOME MARKET FORECAST 2026-2034

UNITED STATES ACUTE CARE AT HOME MARKET OVERVIEW

The United States acute care at home market size is valued at $6,068.08 million as of 2026 and is expected to reach $21,541.02 million by 2034, progressing with a CAGR of 17.16% during the forecast years, 2026–2034.

MARKET INSIGHTS

The United States is a mature and policy-driven market for acute care at home services globally. Federal support has been the single most important structural enabler of this market’s growth.

Moreover, the Centers for Medicare & Medicaid Services (CMS) launched the Acute Hospital Care at Home (AHCAH) initiative in November 2020, granting approved hospitals the regulatory flexibility to deliver inpatient-level care in patients’ homes. By October 2024, 366 hospitals across 38 states had participated in the program, collectively serving over 31,000 patients.

Furthermore, as of September 2025, that figure had grown to 419 approved hospitals across 39 states, according to the American Hospital Association (AHA). In December 2025, the House of Representatives passed the Hospital Inpatient Services Modernization Act (H.R. 4313) by a two-thirds majority, proposing to extend hospital at home programs through 2030.

This legislative momentum is critical. It gives health systems and technology providers the long-term policy certainty needed to invest in scaling their hospital at home market operations with confidence. Beyond federal policy, demographic and economic forces are reinforcing demand across the United States acute care at home market. According to the U.S. Census Bureau, the population aged 65 and older rose by 3.1% to 61.2 million between 2023 and 2024, driven by the aging Baby Boomer generation and rising life expectancy.

This expanding elderly population carries a disproportionately high burden of chronic and acute conditions, including cardiovascular disease, respiratory illness, and post-surgical recovery needs, all of which are addressable through the acute home healthcare model. Additionally, hospital capacity constraints remain severe; hospital at home programs reduce care costs by up to 30% compared to traditional inpatient settings, while also lowering readmission rates and hospital-acquired infection risks. For vendors and investors, these pressures translate into a durable, structurally supported growth runway within the U.S. home-based acute care market.

Strategic partnerships and technology integration are further accelerating this market’s evolution. In February 2024, GE HealthCare and Biofourmis announced a strategic collaboration to extend patient monitoring beyond the hospital, with GE HealthCare distributing Biofourmis’ FDA-cleared, AI-guided remote care solutions to U.S. health systems from Q1 2024.

Similarly, in March 2025, DispatchHealth and Medically Home completed a merger to create the largest advanced at-home care provider in the country, now operating across 50 major metropolitan areas in partnership with nearly 40 health systems. Real-world program data reinforces the case for investment. Ochsner Health’s acute care at home program, launched in 2024, saved over 1,000 bed-days within its first year, per the AMA.

Meanwhile, Kaiser Permanente’s Advanced Care at Home program has consistently achieved 30-day readmission rates below the national average. These developments collectively illustrate how clinical outcomes, commercial scale, and policy alignment are converging to drive the United States acute care at home market forward during the forecast period.